Pathway Analysis of ChIP-Seq-Based NRF1 Target Genes Suggests a Logical Hypothesis of their Involvement in the pathogenesis of Neurodegenerative Diseases

Gene Regulation and Systems Biology

Volumn 2013, Issue 7, 2013, Pages 139-152

  Satoh, Jun Ichi ^a   Kawana, Natsuki ^a   Yamamoto, Yoji ^a  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Binding sites; ChIP seq; Genomejack; NRF1; Parkinson's disease

Indexed keywords

ARGONAUTE 1 PROTEIN; DJ 1 PROTEIN; MITOCHONDRIAL DNA; NUCLEAR RESPIRATORY FACTOR 1; PARKIN; UBIQUITIN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ALZHEIMER DISEASE; ARTICLE; BIOGENESIS; CD47 GENE; CELL CYCLE; CHROMATIN IMMUNOPRECIPITATION; CYCS GENE; DEGENERATIVE DISEASE; DNA DAMAGE; DNA REPAIR; DNA TRANSCRIPTION; E2F6 GENE; EIF2S1 GENE; EIF2S2 GENE; FMR1 GENE; FXR2 GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MAPT GENE; MITOCHONDRIAL DNA REPLICATION; MITOCHONDRIAL GENE; NEUROBLASTOMA CELL; NRF1 GENE; OXIDATIVE PHOSPHORYLATION; PAELR GENE; PARK2 GENE; PARK6 GENE; PARK7 GENE; PARKINSON DISEASE; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN MICROARRAY; PSENEN GENE; RNA METABOLISM; RNA SPLICING; TOMM34 GENE; TRANSLATION INITIATION;

EID: 84887149480     PISSN: None     EISSN: 11776250     Source Type: Journal    
DOI: 10.4137/GRSB.S13204     Document Type: Article

References (39)

1. Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neuro-degenerative diseases. Nature. 2006;443(7113):787-795.
2. McInnes J. Insights on altered mitochondrial function and dynamics in the pathogenesis of neurodegeneration. Transl Neurodegener. 2013;2(1):12.
3. Scarpulla RC. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev. 2008;88(2):611-638.
4. Gugneja S, Scarpulla RC. Serine phosphorylation within a concise amino-terminal domain in nuclear respiratory factor 1 enhances DNA binding. J Biol Chem. 1997;272(30):18732-18739.
5. Virbasius CA, Virbasius JV, Scarpulla RC. NRF-1, an activator involved in nuclear-mitochondrial interactions, utilizes a new DNA-binding domain conserved in a family of developmental regulators. Genes Dev. 1993;7(12A): 2431-2445.
6. Becker TS, Burgess SM, Amsterdam AH, Allende ML, Hopkins N. Not really finished is crucial for development of the zebrafish outer retina and encodes a transcription factor highly homologous to human Nuclear Respiratory Factor-1 and avian Initiation Binding Repressor. Development. 1998;125(22):4369-4378.
7. Huo L, Scarpulla RC. Mitochondrial DNA instability and peri-implantation lethality associated with targeted disruption of nuclear respiratory factor 1 in mice. Mol Cell Biol. 2001;21(2):644-654.
8. DeSimone SM, White K. The Drosophila erect wing gene, which is important for both neuronal and muscle development, encodes a protein which is similar to the sea urchin P3A2 DNA binding protein. Mol Cell Biol. 1993;13(6):3641-3649.
9. Park PJ. ChIP-seq: advantages and challenges of a maturing technology. Nat Rev Genet. 2009;10(10):669-680.
10. Gerstein MB, Kundaje A, Hariharan M, et al. Architecture of the human regulatory network derived from ENCODE data. Nature. 2012;489(7414): 91-100.
11. Satoh J. Bioinformatics approach to identifying molecular biomarkers and networks in multiple sclerosis. Clin Exp Neuroimmunol. 2010;1(3): 127-140.
12. Cam H, Balciunaite E, Blais A, et al. A common set of gene regulatory networks links metabolism and growth inhibition. Mol Cell. 2004;16(3): 399-411.
13. The ENCODE Project Consortium. A user's guide to the Encyclopedia of DNA Elements (ENCODE). PLoS Biol. 2011;9(4):e1001046.
14. Ramagopalan SV, Heger A, Berlanga AJ, et al. defned genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 2010;20(10):1352-1360.
15. Satoh J, Tabunoki H. A comprehensive profle of ChIP-Seq-based STAT1 target genes suggests the complexity of STAT1-mediated gene regulatory mechanisms. Gene Regul Syst Bio. 2013;7:41-56.
16. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44-57.
17. Kanehisa M. Molecular network analysis of diseases and drugs in KEGG. Methods Mol Biol. 2013;939:263-275.
18. Kumari D, Usdin K. Interaction of the transcription factors USF1, USF2, and α-Pal/Nrf-1 with the FMR1 promoter. Implications for Fragile X mental retardation syndrome. J Biol Chem. 2001;276(6):4357-4364.
19. Jacob WF, Silverman TA, Cohen RB, Safer B. Identifcation and characterization of a novel transcription factor participating in the expression of eukaryotic initiation factor 2α. J Biol Chem. 1989;264(34): 20372-20384.
20. Chiorini JA, Miyamoto S, Harkin SJ, Safer B. Genomic cloning and characterization of the human eukaryotic initiation factor-2β promoter. J Biol Chem. 1999;274(7):4195-4201.
21. Evans MJ, Scarpulla RC. Interaction of nuclear factors with multiple sites in the somatic cytochrome c promoter. Characterization of upstream NRF-1, ATF, and intron Sp1 recognition sequences. J Biol Chem. 1989;264(24):14361-14368.
22. Mahishi L, Usdin K. NF-Y, AP2, Nrf1 and Sp1 regulate the fragile X-related gene 2 (FXR2). Biochem J. 2006;400(2):327-335.
23. Kherrouche Z, De Launoit Y, Monte D. The NRF-1/α-PAL transcription factor regulates human E2F6 promoter activity. Biochem J. 2004;383(Pt 3): 529-536.
24. Chang WT, Huang AM. α-Pal/NRF-1 regulates the promoter of the human integrin-associated protein/CD47 gene. J Biol Chem. 2004;279(15): 14542-14550.
25. Blesa JR, Prieto-Ruiz JA, Abraham BA, Harrison BL, Hegde AA, Hernández-Yago J. NRF-1 is the major transcription factor regulating the expression of the human TOMM34 gene. Biochem Cell Biol. 2008;86(1):46-56.
26. Jeppesen DK, Bohr VA, Stevnsner T. DNA repair defciency in neurodegeneration. Prog Neurobiol. 2011;94(2):166-200.
27. Hegde AN, Upadhya SC. Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease. Biochim Biophys Acta. 2011;1809(2):128-40.
28. Chang WT, Chen HI, Chiou RJ, Chen CY, Huang AM. A novel function of transcription factor α-Pal/NRF-1: increasing neurite outgrowth. Biochem Biophys Res Commun. 2005;334(1):199-206.
29. Efok BJ, Chiorini JA, Safer B. A key transcription factor for eukaryotic initiation factor-2α is strongly homologous to developmental transcription factors and may link metabolic genes to cellular growth and development. J Biol Chem. 1994;269(29):18921-18930.
30. Houlden H, Singleton AB. The genetics and neuropathology of Parkinson's disease. Acta Neuropathol. 2012;124(3):325-338.
31. Youle RJ, Narendra DP. Mechanisms of mitophagy. Nat Rev Mol Cell Biol. 2011;12(1):9-14.
32. Narendra DP, Jin SM, Tanaka A, et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol. 2010;8(1):e1000298.
33. Kim RH, Smith PD, Aleyasin H, et al. Hypersensitivity of DJ-1-defcient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxida-tive stress. Proc Natl Acad Sci U S A. 2005;102(14):5215-5220.
34. Imai Y, Soda M, Inoue H, Hattori N, Mizuno Y, Takahashi R. An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticu-lum stress, is a substrate of Parkin. Cell. 2001;105(7):891-902.
35. Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH. Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet. 2006;15(9):1437-1449.
36. Ma T, Trinh MA, Wexler AJ, et al. Suppression of eIF2α kinases alleviates Alzheimer's disease-related plasticity and memory defcits. Nat Neurosci. 2013;16(9):1299-1305.
37. Gu M, Gash MT, Mann VM, Javoy-Agid F, Cooper JM, Schapira AH. Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol. 1996;39(3):385-389.
38. Dunah AW, Jeong H, Griffn A, et al. Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science. 2002;296(5576): 2238-2243.
39. Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, Krainc D. Transcriptional repression of PGC-1α by mutant huntingtin leads to mito-chondrial dysfunction and neurodegeneration. Cell. 2006;127(1):59-69.